References
Buchert R, Tawamie H, Smith C, Uebe S, Innes A , Al Hallak B, Ekici A,
Sticht H, Schwarze B, Lamont R, Parboosingh J, Bernier F, Abou Jamra R.
2014. A Peroxisomal Disorder of Severe Intellectual Disability,
Epilepsy, and Cataracts Due to Fatty Acyl-CoA Reductase 1 Deficiency.
95:602-610.
Cheng JB, Russell DW. 2004. Mammalian Wax Biosynthesis. 279:37789-37797.
Ferdinandusse S, Mcwalter K, Te Brinke H, Ijlst L, Mooijer PM, Ruiter
JPN, Van Lint, Alida E M, Pras-Raves M, Wever E, Millan F, Guillen
Sacoto MJ, Begtrup A, Tarnopolsky M, Brady L, Ladda RL, Sell SL, Nowak
CB, Douglas J, Tian C,…, Vaz FM. 2021. An autosomal dominant
neurological disorder caused by de novo variants in FAR1 resulting in
uncontrolled synthesis of ether lipids. Genetics in Medicine 23:740.
Honsho M, Asaoku S, Fujiki Y. 2010. Posttranslational Regulation of
Fatty Acyl-CoA Reductase 1, Far1, Controls Ether Glycerophospholipid
Synthesis. 285:8537-8542.
Honsho M, Asaoku S, Fukumoto K, Fujiki Y. 2013. Topogenesis and
Homeostasis of Fatty Acyl-CoA Reductase 1. 288:34588-34598.
Online Mendelian Inheritance in Man, OMIM®. Johns
Hopkins University, Baltimore, MD. MIM Number: {616154, 619338}:
{05/20/2021, 02/16/2022}: World Wide Web
URL: https://omim.org/
Table 1. Summary of the clinical manifestations of the 13 patients with
CSPSD